Benchmark Research

Metairie, Louisiana 70006

0 studies enrolling now · 30 studies all time

What they study most

ADHF, Acute Gastroenteritis, Arthritis, CHF, COVID-19, Chronic Heart Failure, Healthy, Healthy or Stable Underlying Chronic Medical Condition, Heart Failure, Hot Flashes, Influenza, Influenza Vaccine

Studies at this site

• A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis — Running, not enrolling
• A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19 — Completed
• Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals — Completed
• A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults — Completed
• Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection — Completed
• The Celljuvant Study: A Phase 3 Immunogenicity and Safety Study of aQIVc Vaccine in Adults Aged 50 Years and Older — Completed
• A Study to Evaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 (COVID-19) Variants — Completed
• Efficacy and Safety of Human Neuregulin-1 to Treat Stable Chronic Heart Failure — Completed
• A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants — Completed
• Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Adults — Completed
• A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years Old — Completed
• Open Label Safety Study in Acute Treatment of Migraine — Completed
• A Phase 2 Study to Evaluate Immune Responses of FluMist® — Completed
• Efficacy And Safety Study Of Tanezumab Subcutaneous Administration In Osteoarthritis - A Subcutaneous/Intravenous Bridging Study — Stopped early
• A Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in Healthy, Vaccinia-naïve Subjects — Completed
• A Study to Evaluate the Immunogenicity of Quadrivalent LAIV (MEDI8662) in Adults 18 to 49 Years of Age — Completed
• A Study to Evaluate the Shedding and Safety of Trivalent Influenza Virus Vaccine Live, Intranasal in Infants and Young Children — Completed
• Safety and Immunogenicity of Flublok Quadrivalent vs IIV4 in Adults 18-49 Years of Age — Completed
• Concomitant Administration of 13-valent Pneumococcal Conjugate Vaccine (13vPnC) With Influenza Vaccine in 23-valent Pneumococcal Polysaccharide (23vPS) Pre-vaccinated Adults. — Completed
• A Trial to Assess the Lot Consistency, Safety, Tolerability and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Subjects Aged ≥10 to <19 Years — Completed
• A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years. — Completed
• Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Children — Completed
• An Extension Study Investigating the Efficacy and Safety of a Fast-Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults — Completed
• Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia — Completed
• Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age — Completed
• Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza. — Completed
• Hymovis™ Versus Placebo in Knee Osteoarthritis — Completed
• PK/PD Study of Subcutaneous Cenderitide Infusion in CHF Patients — Completed
• Estradiol Transdermal Spray in the Treatment of Vasomotor Symptoms — Completed
• Study of TA-NIC to Assess the Efficacy and Safety of the Vaccine as an Aid to Smoking Cessation — Completed